Financials Sino Medical Sciences Technology Inc.

Equities

688108

CNE100003NY2

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 18:00:00 2024-07-02 EDT 5-day change 1st Jan Change
8.84 CNY -1.89% Intraday chart for Sino Medical Sciences Technology Inc. -4.12% -29.56%

Valuation

Fiscal Period: December 2020 2021 2022 2024 2025 2026
Capitalization 1 5,523 3,366 2,341 3,655 - -
Enterprise Value (EV) 1 5,523 3,366 2,341 3,655 3,655 3,655
P/E ratio 269 x -24.9 x -14.6 x 295 x 58.9 x 22.7 x
Yield - - - - - -
Capitalization / Revenue 16.9 x - - 7.69 x 5.3 x 3.38 x
EV / Revenue 16.9 x - - 7.69 x 5.3 x 3.38 x
EV / EBITDA - - - 141 x 40.6 x 17.8 x
EV / FCF - - - -106 x -506 x 62.9 x
FCF Yield - - - -0.95% -0.2% 1.59%
Price to Book 5.12 x - - 0.03 x 0.15 x 0.39 x
Nbr of stocks (in thousands) 410,000 410,000 410,000 413,456 - -
Reference price 2 13.47 8.210 5.710 8.840 8.840 8.840
Announcement Date 21-02-25 22-02-25 23-02-27 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2024 2025 2026
Net sales 1 327.4 - - 475 689 1,080
EBITDA 1 - - - 26 90 205
EBIT 1 24.01 - - 14 81 200
Operating Margin 7.33% - - 2.95% 11.76% 18.52%
Earnings before Tax (EBT) 1 28.84 - - 14 80 201
Net income 1 22.49 -133.9 -161.7 11 63 159
Net margin 6.87% - - 2.32% 9.14% 14.72%
EPS 2 0.0500 -0.3300 -0.3900 0.0300 0.1500 0.3900
Free Cash Flow 1 - - - -34.55 -7.22 58.14
FCF margin - - - -7.27% -1.05% 5.38%
FCF Conversion (EBITDA) - - - - - 28.36%
FCF Conversion (Net income) - - - - - 36.57%
Dividend per Share - - - - - -
Announcement Date 21-02-25 22-02-25 23-02-27 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - - -34.6 -7.22 58.1
ROE (net income / shareholders' equity) 1.93% - - 1.3% 7% 5.1%
ROA (Net income/ Total Assets) 1.75% - - 0.9% 5.1% 11.1%
Assets 1 1,287 - - 1,222 1,235 1,432
Book Value Per Share 2 2.630 - - 294.0 58.70 22.60
Cash Flow per Share 0.1700 - - - - -
Capex 1 113 - - 35 45 55
Capex / Sales 34.38% - - 7.37% 6.53% 5.09%
Announcement Date 21-02-25 22-02-25 23-02-27 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.84 CNY
Average target price
12 CNY
Spread / Average Target
+35.75%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688108 Stock
  4. Financials Sino Medical Sciences Technology Inc.